Moreover, prostate adenocarcinoma patients from the TCGA dataset displaying a tumour mRNA expression level greater than 2-fold above the mean of either ATG4B, ATG4D, ULK1, or ULK2, had poor prognosis. This evidence concerns the gene ULK1 and neoplasm.